Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 558981 - 559000 out of 560238 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (B02BD08) coagulation factor viia | NOVOSEVEN RT 5MG/VIL PF SYR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia A | NovoNordiskInc. |
| USA | (B02BD08) coagulation factor viia | NOVOSEVEN RT 8MG/VIL PF SYR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia A | NovoNordiskInc. |
| USA | (B02BD08) coagulation factor viia | NOVOSEVEN RT 8MG/VIL PF SYR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia A | NovoNordiskInc. |
| USA | (B02BD08) coagulation factor viia | NOVOSEVEN RT 1MG/VIL PF SYR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia A | NovoNordiskInc. |
| USA | (B02BD08) coagulation factor viia | NOVOSEVEN RT 1MG/VIL PF SYR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia A | NovoNordiskInc. |
| USA | (B02BD11) catridecacog | TRETTEN 2000-3125 IU/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovoNordiskInc. |
| USA | (B02BD11) catridecacog | TRETTEN 2000-3125 IU/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovoNordiskInc. |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
| USA | (B02BD16) etranacogene dezaparvovec | HEMGENIX 1x10^13gc/ml | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringLLC |
Pages
